StructIR Lab™ Grant Program
This is time sensitive – so get applying!
06 Dec, 2021 | Newsletters
|You may have noticed our recent email regarding the NEW RedShiftBio system. This powerful new IR-based analytical system uses Microfluidic Modulation Spectroscopy (MMS) to provide direct measurement of previously undetectable changes in protein structure.
We would like to invite you to apply for the new StructIR Lab™ Grant Program, this is time sensitive – so get applying! Also, take a look at UK researcher, Rob Forbes as he presents his findings at the PEGS conference.
NEW StructIR Lab™ Grant Program – APPLY TODAY – Limited time only
The 2021 StructIR Lab Grant program will provide two winners access to the AQS3®pro and Microfluidic Modulation Spectroscopy via our in-house expert staff for sample testing and analysis. Applicants now have until December 15 to complete and submit a grant application, available through the RedShiftBio website, to be considered for this grant. The winners will be selected by a review committee and will be announced on December 22.
Please do not hesitate to contact Peter Davis (Email: email@example.com or call direct 0417 778 971) should you have any questions or requests.
CONTACT US FOR MORE INFORMATION
MMS for Predicting Aggregation & Particle Formation Behaviour During Early Formulation
WATCH NOW – Success at PEGS Europe !!
Insights into predicting aggregation and particle formation behaviour during early formulation screening: The Role of MMS by Rob Forbes, PhD, University of Central Lancashire/ Fujifilm Diosynth Biotechnologies. Watch this presentation now available on-demand.
Differentiation of <2% changes in HOS using Microfluidic Modulation Spectroscopy (MMS)
PEGS Europe Featured Poster Presentation
Confident Differentiation of <2% changes in Secondary Structure to Compare Batch-to-Batch Activity using Microfluidic Modulation Spectroscopy (MMS) by Dr Patrick King, Susana De Jesús Acosta, Dr Roser Llevadot.
Discover how MMS can strengthen your bioanalytical tool kit by providing critical insight through all phases of protein-based drug development.
DOWNLOAD A COPY OF THE BROCHURE